Infektionsmedicinsk Afdeling

Medicin og biovidenskab

1. HIV 100%
2. Hepacivirus 75%
3. Denmark 72%
4. Cohort Studies 47%
5. Genotype 31%
6. HIV-1 30%
7. Coronavirus 28%
8. Infections 25%
9. Mortality 25%
10. Population 22%
11. HIV Infections 22%
12. Viruses 20%
13. Confidence Intervals 20%
14. SARS Virus 20%
15. Chronic Hepatitis C 19%
16. Highly Active Antiretroviral Therapy 18%
17. Refugees 18%
18. Vaccines 18%
19. Bacteremia 17%
20. Virus Diseases 17%
21. CD4 Lymphocyte Count 17%
22. Therapeutics 17%
23. Severe Acute Respiratory Syndrome 16%
24. Antiviral Agents 15%
25. Incidence 15%
26. T-Lymphocytes 13%
27. RNA 13%
28. Neutralizing Antibodies 12%
29. Tuberculosis 12%
30. Cell Culture Techniques 11%
31. Staphylococcus aureus 10%
32. Pneumonia 10%
33. Comorbidity 10%
34. GS-5734 10%
35. Antibodies 10%
36. Vaccination 10%
37. Viral Load 9%
38. Hepatitis C 9%
39. Protease Inhibitors 9%
40. Mutation 9%
41. Odds Ratio 9%
42. Randomized Controlled Trials 9%
43. Child 8%
44. Acquired Immunodeficiency Syndrome 8%
45. Urokinase Plasminogen Activator Receptors 8%
46. Systematic Reviews 7%
47. Delivery of Health Care 7%
48. Placebos 7%
49. Pharmaceutical Preparations 7%
50. Pneumococcal Infections 7%
51. Ribavirin 7%
52. Meningitis 7%
53. Epitopes 7%
54. Lipodystrophy 7%
55. Cross-Sectional Studies 7%
56. Coronavirus Infections 7%
57. Liver 6%
58. Genome 6%
59. Hepatitis 6%
60. Fibrosis 6%
61. Biomarkers 6%
62. Observational Studies 6%
63. Health 6%
64. Serogroup 5%
65. Hospitalization 5%
66. Bacterial Meningitides 5%
67. Hepatitis B virus 5%
68. Pandemics 5%
69. Lung 5%
70. Anti-Bacterial Agents 5%
71. Cardiovascular Diseases 5%
72. Virion 5%
73. Communicable Diseases 5%
74. Coinfection 5%
75. Proteins 5%
76. Chronic Obstructive Pulmonary Disease 5%
77. Liver Diseases 5%
78. Inflammation 5%
79. Prospective Studies 5%
80. Registries 5%
81. Fecal Microbiota Transplantation 5%
82. Chronic Hepatitis B 5%
83. Retrospective Studies 5%
84. Logistic Models 5%
85. Genes 5%
86. Guidelines 5%